Literature DB >> 7709073

Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype.

X S Lü1, J F Delfraissy, L Grangeot-Keros, M T Rannou, J Pillot.   

Abstract

Anti-HIV antibodies can be specifically detected with a sensitivity and a specificity of 100% in the saliva of all HIV-infected patients. A saliva collection device facilitates the sampling procedure, and if a rapid test is used, the diagnosis of infection can be established in as little as 10 min. The analysis of a group of CDC stage IV AIDS patients showed a decrease in lactoferrin (produced by the oral mucosa) in comparison with HIV-negative controls, associated with an increase in albumin (filtering from plasma), indicating an alteration of the mucosal barrier. The salivary anti-HIV-gp160 activity was largely carried by the IgG isotype whereas the salivary antibacterial activity (anti-Streptococcus sobrinus; anti-LPS from Escherichia coli) remained located in the IgA isotype as usually observed with all infectious agents. Salivary IgG carried a specific anti-gp160 activity 25-fold higher than that of serum IgG. Thus, significant local synthesis of specific IgG by oral mucosa was revealed as a characteristic of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7709073     DOI: 10.1016/s0923-2516(07)80042-2

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  12 in total

1.  New method for quantifying anti-HIV1-gp160 antibodies in saliva, cervicovaginal secretions, and serum of infected women.

Authors:  F X Lü
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Influence of host factors on immunoglobulin G concentration in oral fluid specimens.

Authors:  Timothy C Granade; Susan K Phillips; Wendy Kitson-Piggott; Perry Gomez; Bisram Mahabir; Herbert Oleander; J Richard George; James Baggs; Bharat Parekh
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 3.  Detection of human immunodeficiency virus antibodies in oral fluids.

Authors:  R L Hodinka; T Nagashunmugam; D Malamud
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

4.  Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.

Authors:  L Bélec; C Tévi-Bénissan; T Dupré; A S Mohamed; T Prazuck; J Gilquin; J M Kanga; J Pillot
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

5.  Thyrotropin receptor antibodies in parotid saliva.

Authors:  O R Tumilasci; M C Arqueros; M A Ostuni; E el Tamer; A B Houssay
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

6.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals.

Authors:  Xueling Wu; Susan Jackson
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

8.  Evaluation of two novel immunoassays designed to detect HIV antibodies in oral fluids.

Authors:  R D Saville; N T Constantine; C Holm-Hansen; C Wisnom; L DePaola; W A Falkler
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

9.  Detection of antibodies to human immunodeficiency virus type 1 in oral fluids: a large-scale evaluation of immunoassay performance.

Authors:  T C Granade; S K Phillips; B Parekh; P Gomez; W Kitson-Piggott; H Oleander; B Mahabir; W Charles; S Lee-Thomas
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

Review 10.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.